DB11997InvestigationalProtein Based Therapies
Interleukin 7 has been used in trials studying the treatment of Metastatic Breast Cancer.
- Mechanism
- Curator reviewed
Interleukin-7 human recombinant is a recombinant format of IL-7, a growth factor for T-cells which is shown to help restore and maintain lymphocyte counts, including both CD4+ and CD8+ T-cells, increasing the numbers of functional T-cells. The exact mechanism of action behind this is currently unknown.
- Also known as
- Glycosylated recombinant human interleukin-7 · IL-7 · IL7 · Interleukin 7 glycosylated · SH-polypeptide-42
- Code names
- CYT-107
Resolves to
Compound
Clinical / RWD
Targets
What you can answer from here — as of July 09, 2026
Which drugs share a target with Interleukin-7, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account